Evidence map›Paper›PMID 42060660›Full record

ArticlePloS one2026

Mortality predictors, hepatic involvement patterns, and the steatotic liver paradox in 1,484 hospitalized Dengue patients.

Aryalakshmi Sreemohan, Arif Hussain Theruvath, Ambily Baby, Cyriac Abby Philips, Tharun Tom Oommen, Santhichandra Pai, Salini Baby John, Jaicob Varghese, Rizwan Ahamed, Ajit Tharakan and 1 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aryalakshmi SreemohanClinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.
Arif Hussain TheruvathClinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.
Ambily BabyClinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.
Cyriac Abby PhilipsClinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.ORCID https://orcid.org/0000-0002-9587-336X
Tharun Tom OommenDepartment of Clinical and Translational Hepatology, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.
Santhichandra PaiDepartment of General (Internal) Medicine, Rajagiri Hospital, Aluva, Kerala, India.
Salini Baby JohnDepartment of General (Internal) Medicine, Rajagiri Hospital, Aluva, Kerala, India.
Jaicob VargheseDepartment of Intensive Medicine and Critical Care, Rajagiri Hospital, Aluva, Kerala, India.
Rizwan AhamedDepartment of Gastroenterology and Advanced GI Endoscopy, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.
Ajit TharakanDepartment of Gastroenterology and Advanced GI Endoscopy, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.
Philip AugustineDepartment of Gastroenterology and Advanced GI Endoscopy, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesDengue fever represents a major global health burden with hepatic involvement occurring in up to 90% of hospitalized patients. This study aimed to determine in-hospital mortality predictors, characterize clinical outcomes across graded hepatic injury phenotypes, and validate prognostic scoring systems in hospitalized dengue patients. A primary focus was assessing the impact of pre-existing liver conditions on disease trajectory and survival.

methodsA retrospective cohort analysis was conducted on 1,484 patients with laboratory-confirmed dengue infection admitted to a tertiary-care center between 2021 and 2024. Patients were stratified by hepatic status into those with pre-existing chronic liver disease, non-chronic steatotic liver involvement, and no liver involvement. Multivariable logistic regression identified independent mortality predictors, while unsupervised clustering distinguished clinical phenotypes. The performance of physiological and liver-specific prognostic scores was evaluated against clinical outcomes.

resultsThe overall in-hospital mortality rate was 5.1%, with 13.1% requiring intensive care admission. Independent predictors of mortality included severe dengue classification, intensive care unit admission, elevated neutrophil-to-lymphocyte ratio, and hypoalbuminemia, with albumin emerging as the strongest single biomarker for risk prediction. Paradoxically, patients with steatotic liver disease demonstrated improved survival compared to those without pre-existing liver disease, supporting an "obesity paradox" in this tropical infection context, whereas decompensated cirrhosis was associated with markedly adverse outcomes. The Albumin-Bilirubin grade successfully stratified hepatic risk, and the Simplified Acute Physiology Score-3 significantly outperformed the Sequential Organ Failure Assessment for predicting mortality in critically ill patients. Four distinct clinical phenotypes with differential mortality ranging from 3.0% to 100% were identified.

conclusionsHypoalbuminemia serves as a critical, accessible prognostic marker in dengue fever. Pre-existing liver pathology demonstrates divergent impacts on outcomes, with steatotic liver disease potentially conferring survival advantage contrary to traditional metabolic risk assumptions. These findings support the utility of liver-specific scoring systems for acute risk stratification in dengue-endemic regions.

Indexed as

DengueFatty LiverAdultFemaleHospitalizationHospital MortalityHumansLiverMaleMiddle AgedPrognosisRetrospective Studies

Identifiers

PMID42060660
PMCPMC13132437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.